6-[5-AMINO-6-(2-ETHOXYETHOXY)-IMIDAZO[4,5-B]PYRIDIN-3-YL]-NICOTI NONITRILE DERIVATIVES AND THEIR USE AS IRAK INHIBITORS

The present invention discloses compounds according to Formula (I): wherein R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting IRAK family kinases, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using t...

Full description

Saved in:
Bibliographic Details
Main Authors Reginald Christophe Xavier BRYS, Agnès Marie JONCOUR, Frédéric Gilbert LABÉGUÈRE, Christel Jeanne Marie MENET, Benoît Antoine SCHMITT, Oscar MAMMOLITI, Jean- Michel LEFRANCOIS, Julien Georges Pierre- Olivier DOYON, Steven Emiel VAN DER PLAS, Raphaël Jean Joël GENEY
Format Patent
LanguageEnglish
Spanish
Published 27.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention discloses compounds according to Formula (I): wherein R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting IRAK family kinases, methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of inflammatory diseases, autoimmune diseases and/or proliferative diseases by administering the compound of the invention. La presente invención describe compuestos de acuerdo con la Fórmula I: (ver Fórmula) en donde R1, R2, y Cy son como se definen en el presente documento. La presente invención se refiere a compuestos que inhiben las cinasas de la familia IRAK, métodos para su producción, composiciones farmacéuticas que comprenden los mismos, y métodos de tratamiento que utilizan los mismos, para la profilaxis y/o tratamiento de enfermedades inflamatorias, enfermedades autoinmunes y/o enfermedades proliferativas mediante la administración del compuesto de la invención.
Bibliography:Application Number: MX20180004517